Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases
出版年份 2023 全文链接
标题
Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases
作者
关键词
-
出版物
JOURNAL OF NEURO-ONCOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-28
DOI
10.1007/s11060-023-04471-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer
- (2023) Xin Chen et al. Journal of Translational Medicine
- Pan-cancer whole-genome comparison of primary and metastatic solid tumours
- (2023) Francisco Martínez-Jiménez et al. NATURE
- The evolution of lung cancer and impact of subclonal selection in TRACERx
- (2023) Alexander M. Frankell et al. NATURE
- Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial
- (2023) Juliann Chmielecki et al. Nature Communications
- The Genomic Landscape of Melanoma and Its Therapeutic Implications
- (2023) Ting-Ting Yang et al. Genes
- Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing
- (2022) Hainan Yang et al. BMC CANCER
- Glioma progression is shaped by genetic evolution and microenvironment interactions
- (2022) Frederick S. Varn et al. CELL
- Landscape of somatic alterations in large-scale solid tumors from an Asian population
- (2022) Liqun Wu et al. Nature Communications
- Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis
- (2022) Naifu Nie et al. Thoracic Cancer
- Liquid biopsy: current technology and clinical applications
- (2022) Mina Nikanjam et al. Journal of Hematology & Oncology
- Sequencing of cerebrospinal fluid in non‐small‐cell lung cancer patients with leptomeningeal metastasis: A systematic review
- (2022) Tianqi Gao et al. Cancer Medicine
- Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
- (2022) Meichen Li et al. BMC Medicine
- Human TERT promoter mutations as a prognostic biomarker in glioma
- (2021) Branka Powter et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Liquid Biopsy: From Discovery to Clinical Application
- (2021) Catherine Alix-Panabières et al. Cancer Discovery
- FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring
- (2021) Jolijn W. Groeneweg et al. GYNECOLOGIC ONCOLOGY
- Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)
- (2021) Jingyi He et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Toward personalized treatment approaches for non-small-cell lung cancer
- (2021) Meina Wang et al. NATURE MEDICINE
- Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
- (2021) Longfei Lin et al. Journal of Hematology & Oncology
- Programmable base editing of mutated TERT promoter inhibits brain tumour growth
- (2020) Xinjian Li et al. NATURE CELL BIOLOGY
- Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing
- (2020) Yue Zhao et al. BMC CANCER
- Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
- (2020) Feng Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases
- (2020) Yang-Si Li et al. JAMA Network Open
- Genotyping of cerebrospinal fluid associated with osimertinib response and resistance for leptomeningeal metastases in EGFR-mutated non-small cell lung cancer
- (2020) Mei-Mei Zheng et al. Journal of Thoracic Oncology
- TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti‐CTLA4 treatment
- (2020) Huahua Li et al. Cancer Medicine
- The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non‐small‐cell lung cancer‐a retrospective study from one single cancer institute
- (2019) Weiwei Yan et al. Cancer Medicine
- Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis
- (2019) Yue Zhao et al. BMC Neurology
- Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
- (2018) Y S Li et al. ANNALS OF ONCOLOGY
- Leptomeningeal Metastases
- (2018) Jerome J. Graber et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Leptomeningeal metastases in non-small-cell lung cancer
- (2018) Haiying Cheng et al. LANCET ONCOLOGY
- Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
- (2018) R. Minari et al. LUNG CANCER
- Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
- (2018) Geoffrey R. Oxnard et al. JAMA Oncology
- Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC
- (2017) Franciele H. Knebel et al. LUNG CANCER
- METCopy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis ofEGFR-mutant Lung Cancer
- (2017) Shigeki Nanjo et al. MOLECULAR CANCER THERAPEUTICS
- Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors
- (2017) Xuling Lin et al. NEURO-ONCOLOGY
- Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA
- (2017) Michael Offin et al. Journal of Oncology
- TERTpromoter mutations and long-term survival in patients with thyroid cancer
- (2016) Tae Hyuk Kim et al. ENDOCRINE-RELATED CANCER
- Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
- (2016) Elena I. Pentsova et al. JOURNAL OF CLINICAL ONCOLOGY
- Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations
- (2016) Yang-Si Li et al. Journal of Thoracic Oncology
- Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity
- (2015) Kenichi Suda et al. ARCHIVES OF TOXICOLOGY
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
- (2015) Leticia De Mattos-Arruda et al. Nature Communications
- TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
- (2014) Klaus G. Griewank et al. JNCI-Journal of the National Cancer Institute
- TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
- (2014) Aden Ka-Yin Chan et al. MODERN PATHOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan
- (2008) Toshimi Takano et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started